Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomas Vilimas

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|September 11, 2019
Measuring Tumor Mutational Burden Using Whole-Exome SequencingTomas Vilimas
Cell Cycle (Georgetown, Tex.)|March 3, 2007
Notches, NFkappaBs and the making of T cell leukemiaIannis Aifantis, Tomas Vilimas, Silvia Buonamici
Developmental Biology|January 24, 2004
An early pharyngeal muscle enhancer from the Caenorhabditis elegans ceh-22 gene is targeted by the Forkhead factor PHA-4Tomas Vilimas, Alin Abraham, Peter G Okkema
Immunological Reviews|February 2, 2006
Regulation of T-cell progenitor survival and cell-cycle entry by the pre-T-cell receptorIannis Aifantis, Malay Mandal, Katie Sawai, et al.
The Journal of Experimental Medicine|July 25, 2007
The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemiaBenjamin J Thompson, Silvia Buonamici, Maria Luisa Sulis, et al.
Blood|February 2, 2006
Notch1 promotes survival of E2A-deficient T cell lymphomas through pre-T cell receptor-dependent and -independent mechanismsErica J Reschly, Christina Spaulding, Tomas Vilimas, et al.
Nature Medicine|December 19, 2006
Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemiaTomas Vilimas, Joaquina Mascarenhas, Teresa Palomero, et al.
Molecular Biology of the Cell|August 20, 2010
Sprouty proteins inhibit receptor-mediated activation of phosphatidylinositol-specific phospholipase CSimge Akbulut, Alagarsamy L Reddi, Priya Aggarwal, et al.
Cancer Chemotherapy and Pharmacology|October 12, 2018
Pharmacokinetic evaluation of the PNC disassembler metarrestin in wild-type and Pdx1-Cre;LSL-Kras<sup>G12D/+</sup>;Tp53<sup>R172H/+</sup> (KPC) mice, a genetically engineered model of pancreatic cancerTomas Vilimas, Amy Q Wang, Samarjit Patnaik, et al.
Cancer Research|November 17, 2019
Clinical Evolution of Epithelial-Mesenchymal Transition in Human CarcinomasTony Navas, Robert J Kinders, Scott M Lawrence, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|September 11, 2019
Measuring Tumor Mutational Burden Using Whole-Exome SequencingTomas Vilimas
Cell Cycle (Georgetown, Tex.)|March 3, 2007
Notches, NFkappaBs and the making of T cell leukemiaIannis Aifantis, Tomas Vilimas, Silvia Buonamici
Developmental Biology|January 24, 2004
An early pharyngeal muscle enhancer from the Caenorhabditis elegans ceh-22 gene is targeted by the Forkhead factor PHA-4Tomas Vilimas, Alin Abraham, Peter G Okkema
Immunological Reviews|February 2, 2006
Regulation of T-cell progenitor survival and cell-cycle entry by the pre-T-cell receptorIannis Aifantis, Malay Mandal, Katie Sawai, et al.
The Journal of Experimental Medicine|July 25, 2007
The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemiaBenjamin J Thompson, Silvia Buonamici, Maria Luisa Sulis, et al.
Blood|February 2, 2006
Notch1 promotes survival of E2A-deficient T cell lymphomas through pre-T cell receptor-dependent and -independent mechanismsErica J Reschly, Christina Spaulding, Tomas Vilimas, et al.
Nature Medicine|December 19, 2006
Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemiaTomas Vilimas, Joaquina Mascarenhas, Teresa Palomero, et al.
Molecular Biology of the Cell|August 20, 2010
Sprouty proteins inhibit receptor-mediated activation of phosphatidylinositol-specific phospholipase CSimge Akbulut, Alagarsamy L Reddi, Priya Aggarwal, et al.
Cancer Chemotherapy and Pharmacology|October 12, 2018
Pharmacokinetic evaluation of the PNC disassembler metarrestin in wild-type and Pdx1-Cre;LSL-Kras<sup>G12D/+</sup>;Tp53<sup>R172H/+</sup> (KPC) mice, a genetically engineered model of pancreatic cancerTomas Vilimas, Amy Q Wang, Samarjit Patnaik, et al.
Cancer Research|November 17, 2019
Clinical Evolution of Epithelial-Mesenchymal Transition in Human CarcinomasTony Navas, Robert J Kinders, Scott M Lawrence, et al.
Pageof 2